Lumen Bioscience, Inc.

Seattle, WA Doing business as Lumen Bioscience

UEI
E9UJDT3BFUQ5
CAGE
7UBN7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1441 N 34th St #300, Seattle, WA 98103, USA
Website
lumen.bio
Founded
2017
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Lumen Bioscience, Inc.

Lumen Bioscience Inc. is a biotechnology company that specializes in synthesizing high-value products using a novel platform organism. Through federal contracts and grants, Lumen Bioscience provides biological research and development services, including developing biologic drugs and therapeutic delivery platforms.

Lumen Bioscience has received prime federal contracts to provide an intranasal antibody cocktail delivery platform to the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, supporting mitigation of long-term respiratory distress. As a subcontractor, Lumen Bioscience is developing an oral vaccine candidate to prevent diarrheal diseases caused by C. jejuni and Enterotoxigenic E. coli for the Trustees of Boston University.

Through federal grants, Lumen Bioscience is conducting a Phase 2/3 clinical trial investigating an anti-infective therapeutic to treat and prevent C. difficile infection, funded by the Defense Health Agency's Military Medical Research and Development program. Lumen Bioscience also received a Department of Energy grant to develop alkaline carbon capture and expression-streamlined Spirulina cultivated in air for reliable bioproducts, oil and nutrition. As a subgrantee, Lumen Bioscience is delivering novel therapies to enhance and repair glomerular regeneration for the University of Washington, and developing an oral vaccine candidate to prevent C. jejuni and Enterotoxigenic E. coli diarrheal diseases for the Trustees of Boston University.

Quick answers

What is Lumen Bioscience, Inc.'s UEI?

Lumen Bioscience, Inc.'s Unique Entity ID (UEI) in SAM.gov is E9UJDT3BFUQ5.

What is Lumen Bioscience, Inc.'s CAGE code?

Lumen Bioscience, Inc.'s CAGE code is 7UBN7.

What is Lumen Bioscience, Inc.'s primary NAICS code?

Lumen Bioscience, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Lumen Bioscience, Inc. located?

Lumen Bioscience, Inc.'s physical address in SAM.gov is 1441 N 34th St #300, Seattle, WA 98103, USA.

Is Lumen Bioscience, Inc. registered in SAM.gov?

Yes. Lumen Bioscience, Inc.'s SAM.gov registration is active through December 18, 2026.

What is Lumen Bioscience, Inc.'s most recent federal award?

Lumen Bioscience, Inc.'s most recent federal grant award is A phase 2/3, randomized, double-blind, placebo-controlled study of LMN-201 for treatment and prevention of c.… (HT94252310959), from Defense Health Agency, on September 15, 2023.

On GovTribe

See Lumen Bioscience, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors